Skip to content

Clinical trials

Phase 1 Prostatic Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Country / region: Belgium Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20082
20111
20121
20181
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
University Hospital, Ghent2
Amgen1
Eli Lilly and Company1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms12
Esophageal Neoplasms2
Bites and Stings1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Head and Neck Neoplasms1
Myofibroma1
Neoplasm Metastasis1
Ovarian Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.